Back to search

Article

Framework for prioritizing variants of unknown significance from clinical genetic testing in kidney disease – utility of multidisciplinary approach to gather evidence of pathogenicity for Hepatocyte Nuclear Factor-1β (<i>HNF1B</i>) p.Arg303His

2022-04-05

Abstract excerpt

Monogenic causes in over 300 kidney-associated genes account for roughly 12% of end stage kidney disease (ESKD) cases. Advances in next generation sequencing, and large customized panels enable the diagnosis of monogenic kidney disease noninvasively at relatively low cost, allowing for more precise management for patients and their families. A major challenge is interpreting rare variants, many of which are classi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ccc1b66e-bd2f-5b28-a2e4-cc9c56fae1d1
DOI
10.1101/2022.04.01.22273321
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Framework for prioritizing variants of unknown significance from clinical genetic testing in kidney disease – utility of multidisciplinary approach to gather evidence of pathogenicity for Hepatocyte Nuclear Factor-1β (<i>HNF1B</i>) p.Arg303HisDOI 10.1101/2022.04.01.22273321
Select a neighboring publication to make it the new centre.